FLNA
Filana Therapeutics, Inc. NASDAQ Listed Jul 14, 2000$0.74
After hrs
$0.74
+0.07%
Mkt Cap $35.7M
52w Low $0.68
3.1% of range
52w High $2.45
50d MA $0.91
200d MA $1.38
P/E (TTM)
-0.8x
EV/EBITDA
—
P/B
0.5x
Debt/Equity
0.0x
ROE
-122.3%
P/FCF
-1.1x
RSI (14)
23.00
ATR (14)
$0.05
Beta
-0.68
50d MA
$0.91
200d MA
$1.38
Avg Volume
271.1K
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
6801 N. Capital of Texas Highway · Austin, TX 78731 · US
Data updated apr 25, 2026 9:21am
· Source: financialmodelingprep.com